• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Iclusig

Pharma

BioNTech, Astellas, Daiichi—Fierce Pharma Asia

BioNTech bought a Novartis facility in Singapore. Astellas' CLDN18.2 drug posted a trial win. Daiichi reported positive readout for its mRNA booster.
Angus Liu Nov 18, 2022 10:11am

In Ph+ALL trial, Takeda's Iclusig outdoes Novartis' Gleevec

Nov 17, 2022 10:27am

Novartis wins CML nod for new Gleevec follow-on Scemblix

Nov 1, 2021 6:51am

Takeda, Astellas, Everest-Providence and more—Fierce Pharma Asia

Sep 17, 2021 9:05am

Takeda will not sign off on trial which could repurpose drug

Sep 15, 2021 7:37am

Takeda, China's COVID-19 vaccines and more—FiercePharmaAsia

Dec 11, 2020 9:25am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy